2022
The Evolution of Evidence-Based Medicine: When the Magic of the Randomized Clinical Trial Meets Real-World Data
You SC, Krumholz HM. The Evolution of Evidence-Based Medicine: When the Magic of the Randomized Clinical Trial Meets Real-World Data. Circulation 2022, 145: 107-109. PMID: 35007161, DOI: 10.1161/circulationaha.121.057931.Peer-Reviewed Original Research
2020
Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov
Pundi K, Perino AC, Harrington RA, Krumholz HM, Turakhia MP. Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov. JAMA Internal Medicine 2020, 180: 1398-1400. PMID: 32730617, PMCID: PMC7385669, DOI: 10.1001/jamainternmed.2020.2904.Peer-Reviewed Original Research
2019
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, Reich CG, Duke J, Madigan D, Hripcsak G, Ryan PB. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. The Lancet 2019, 394: 1816-1826. PMID: 31668726, PMCID: PMC6924620, DOI: 10.1016/s0140-6736(19)32317-7.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsCalcium Channel BlockersChildCohort StudiesComparative Effectiveness ResearchDatabases, FactualDiureticsEvidence-Based MedicineFemaleHeart FailureHumansHypertensionMaleMiddle AgedMyocardial InfarctionStrokeYoung AdultConceptsNon-dihydropyridine calcium channel blockersCalcium channel blockersThiazide-like diureticsChannel blockersEnzyme inhibitorsDrug classesHazard ratioCurrent guidelinesFirst-line antihypertensive drug classesComparative effectivenessFirst-line drug classesNew-user cohort designDihydropyridine calcium channel blockerElectronic health record databaseFirst-line classesAngiotensin receptor blockersAntihypertensive drug classesAcute myocardial infarctionHealth record databaseReal-world evidenceMedical Research CouncilMillions of patientsAustralian National HealthOptimal monotherapyReceptor blockersTraditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study
Yu Y, Spatz ES, Tan Q, Liu S, Lu Y, Masoudi FA, Schulz WL, Krumholz HM, Li J, Group T. Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study. Journal Of The American Heart Association 2019, 8: e012776. PMID: 31364457, PMCID: PMC6761625, DOI: 10.1161/jaha.119.012776.Peer-Reviewed Original ResearchConceptsTraditional Chinese medicineAcute heart failureHeart failureEvidence-based therapiesWestern Medicine HospitalTCM useMedicine HospitalEvidence-based therapy useTraditional Chinese medicine useChinese medicine useCoronary artery diseaseHeart Failure StudyHierarchical logistic regression modelsLogistic regression modelsSalvia miltiorrhizaRandom sampleHospital bleedingPatient's bleedingPatient characteristicsArtery diseaseTherapy useMedicine useHospital characteristicsRetrospective analysisHospital use
2017
Treatment of Cholesterol in 2017
Krumholz HM. Treatment of Cholesterol in 2017. JAMA 2017, 318: 417-418. PMID: 28738130, DOI: 10.1001/jama.2017.6753.Peer-Reviewed Original Research
2016
Access to Evidence-Based Statins in Low-Cost Generic Drug Programs
Jackevicius CA, Choi K, Krumholz HM. Access to Evidence-Based Statins in Low-Cost Generic Drug Programs. Circulation Cardiovascular Quality And Outcomes 2016, 9: 785-787. PMID: 27803089, DOI: 10.1161/circoutcomes.116.002985.Peer-Reviewed Original ResearchStatins evidence: when answers also raise questions
Krumholz HM. Statins evidence: when answers also raise questions. The BMJ 2016, 354: i4963. PMID: 27628589, DOI: 10.1136/bmj.i4963.Peer-Reviewed Original Research
2015
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, O'Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE, Chung MK, de Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction. Circulation 2015, 133: 1135-1147. PMID: 26490017, DOI: 10.1161/cir.0000000000000336.Peer-Reviewed Original ResearchAchieving best outcomes for patients with cardiovascular disease in China by enhancing the quality of medical care and establishing a learning health-care system
Jiang L, Krumholz HM, Li X, Li J, Hu S. Achieving best outcomes for patients with cardiovascular disease in China by enhancing the quality of medical care and establishing a learning health-care system. The Lancet 2015, 386: 1493-1505. PMID: 26466053, PMCID: PMC5323019, DOI: 10.1016/s0140-6736(15)00343-8.Peer-Reviewed Original ResearchMedication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures
Allen LA, Fonarow GC, Liang L, Schulte PJ, Masoudi FA, Rumsfeld JS, Ho PM, Eapen ZJ, Hernandez AF, Heidenreich PA, Bhatt DL, Peterson ED, Krumholz HM. Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures. Circulation 2015, 132: 1347-1353. PMID: 26316616, PMCID: PMC4941099, DOI: 10.1161/circulationaha.115.014281.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overBody Mass IndexCardiovascular AgentsComorbidityContraindicationsCross-Sectional StudiesDrug HypersensitivityDrug PrescriptionsDrug SubstitutionDrug Therapy, CombinationDrug UtilizationEvidence-Based MedicineFemaleGuideline AdherenceHeart FailureHospitalsHumansMaleMedication AdherenceMiddle AgedPatient AdmissionPatient DischargePolypharmacyPractice Guidelines as TopicQuality Assurance, Health CareConceptsHF quality measuresHydralazine/isosorbide dinitrateAngiotensin receptor blockersMedication groupHeart failureAldosterone antagonistsReceptor blockersMedication regimenIsosorbide dinitrateNew medicationsΒ-blockersEnzyme inhibitorsGuideline-directed medical therapyInitiation of angiotensinPrimary discharge diagnosisQuarter of patientsPatient's medication regimenHospital quality measuresAdequate prescribingMedication initiationHospital dischargeHospital admissionMedical therapyGuideline recommendationsDischarge diagnosis
2014
Descriptions and Interpretations of the ACCORD-Lipid Trial in the News and Biomedical Literature: A Cross-Sectional Analysis
Downing NS, Cheng T, Krumholz HM, Shah ND, Ross JS. Descriptions and Interpretations of the ACCORD-Lipid Trial in the News and Biomedical Literature: A Cross-Sectional Analysis. JAMA Internal Medicine 2014, 174: 1176-1182. PMID: 24796406, PMCID: PMC4124903, DOI: 10.1001/jamainternmed.2014.1371.Peer-Reviewed Original ResearchConceptsACCORD lipid trialACCORD-LipidFibrate useTrial interpretationImproved cardiovascular outcomesCross-sectional studyCross-sectional analysisStatin therapyCardiovascular outcomesCardiovascular riskDiabetes (ACCORD) trialDiabetes mellitusConflicts of interestTrialsPatientsFenofibrateAuthor conflictsLipid componentsMellitusTherapyPhysiciansMonthsMoving Forward From rhBMP-2
Low JB, Ross JS, Krumholz HM. Moving Forward From rhBMP-2. Spine 2014, 39: 531-532. PMID: 24503690, PMCID: PMC3981828, DOI: 10.1097/brs.0000000000000256.Commentaries, Editorials and LettersBone Morphogenetic Protein 2Clinical Trials as TopicEvidence-Based MedicineHumansRecombinant ProteinsStrategies to Reduce Heart Failure Readmissions
Bradley EH, Curry LA, Krumholz HM. Strategies to Reduce Heart Failure Readmissions. JAMA 2014, 311: 1160-1160. PMID: 24643613, DOI: 10.1001/jama.2014.678.Peer-Reviewed Original Research
2013
How Do We Know the Value of Our Research?
Krumholz HM. How Do We Know the Value of Our Research? Circulation Cardiovascular Quality And Outcomes 2013, 6: 371-372. PMID: 23838103, PMCID: PMC5459392, DOI: 10.1161/circoutcomes.113.000423.Peer-Reviewed Original ResearchPromoting Publication of Rigorous Qualitative Research
Krumholz HM, Bradley EH, Curry LA. Promoting Publication of Rigorous Qualitative Research. Circulation Cardiovascular Quality And Outcomes 2013, 6: 133-134. PMID: 23481529, DOI: 10.1161/circoutcomes.113.000186.Peer-Reviewed Original ResearchWhen Choosing Statin Therapy: The Case for Generics
Green JB, Ross JS, Jackevicius CA, Shah ND, Krumholz HM. When Choosing Statin Therapy: The Case for Generics. JAMA Internal Medicine 2013, 173: 229-232. PMID: 23303273, DOI: 10.1001/jamainternmed.2013.1529.Commentaries, Editorials and LettersMeSH KeywordsCardiovascular DiseasesChoice BehaviorDrugs, GenericDyslipidemiasEvidence-Based MedicineHumansHydroxymethylglutaryl-CoA Reductase InhibitorsTherapeutic EquivalencyTamiflu: 14 flu seasons and still questions
Krumholz HM, Jackevicius CA, Ross JS. Tamiflu: 14 flu seasons and still questions. The BMJ 2013, 346: f547. PMID: 23355545, DOI: 10.1136/bmj.f547.Commentaries, Editorials and LettersMeSH KeywordsAntiviral AgentsDisease OutbreaksEvidence-Based MedicineHumansInfluenza, HumanOseltamivirTreatment Outcome
2012
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O’Gara P, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso JE, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Circulation 2012, 127: 529-555. PMID: 23247303, DOI: 10.1161/cir.0b013e3182742c84.Peer-Reviewed Original ResearchAmerican Heart AssociationCardiologyDiagnostic Techniques, CardiovascularDisease ManagementElectrocardiographyEmergency Medical ServicesEvidence-Based MedicineHumansMedication Therapy ManagementMyocardial InfarctionMyocardial ReperfusionPatient SelectionPercutaneous Coronary InterventionRisk AssessmentThrombolytic TherapyUnited States2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal Of The American College Of Cardiology 2012, 61: e78-e140. PMID: 23256914, DOI: 10.1016/j.jacc.2012.11.019.Peer-Reviewed Original ResearchAmerican Heart AssociationCardiologyClinical ProtocolsCoronary Artery BypassDiagnostic Techniques, CardiovascularDisease ManagementElectrocardiographyEmergency Medical ServicesEvidence-Based MedicineHumansMedication Therapy ManagementMyocardial InfarctionMyocardial ReperfusionPatient SelectionPercutaneous Coronary InterventionRisk AssessmentThrombolytic TherapyUnited States2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Circulation 2012, 127: e362-e425. PMID: 23247304, DOI: 10.1161/cir.0b013e3182742cf6.Peer-Reviewed Original ResearchAmerican Heart AssociationCardiologyClinical ProtocolsDiagnostic Techniques, CardiovascularDisease ManagementElectrocardiographyEmergency Medical ServicesEvidence-Based MedicineHumansMedication Therapy ManagementMyocardial InfarctionMyocardial ReperfusionPatient SelectionPercutaneous Coronary InterventionRisk AssessmentThrombolytic TherapyUnited States